Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Huntington's disease genetics.

Richard H Myers1

  • 1Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 02118, USA. rmyers@bu.edu

Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|February 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transposable element small RNAs and large RNAs in aging brains and implications in Huntington's and Parkinson's disease.

Genome research·2026
Same author

Astrocytic noncanonical WNT5B signaling modulates extracellular matrix remodeling and neuropathology in Huntington's disease.

Signal transduction and targeted therapy·2026
Same author

Transposable element small and long RNAs in aging brains and implications in Huntington's and Parkinson's disease.

bioRxiv : the preprint server for biology·2024
Same author

Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects.

bioRxiv : the preprint server for biology·2024
Same author

Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies.

bioRxiv : the preprint server for biology·2024
Same author

Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease.

Progress in neurobiology·2021

Huntington's disease (HD) is a progressive neurodegenerative disorder caused by CAG repeat expansion in the HD gene. Genetic testing is available for diagnosis, risk assessment, and prenatal screening, aiding informed decisions.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Huntington's disease (HD) is an inherited neurodegenerative disorder.
  • It is characterized by progressive motor, cognitive, and psychiatric symptoms.
  • HD is caused by an expanded CAG trinucleotide repeat in the HD gene.

Purpose of the Study:

  • To explain the genetic basis of Huntington's disease.
  • To describe the role of CAG repeat numbers in disease expression and penetrance.
  • To outline the applications and implications of genetic testing for HD.

Main Methods:

  • Genetic analysis of CAG repeat length in the HD gene.
  • Correlation of repeat numbers with disease onset, symptoms, and inheritance patterns.
  • Review of genetic testing protocols and their psychological support.

Related Experiment Videos

Main Results:

  • CAG repeat expansions of 40 or more cause HD.
  • Repeat numbers between 36-39 are associated with reduced penetrance.
  • Intermediate repeats (27-35) can expand in paternal transmission, leading to disease in offspring.

Conclusions:

  • Genetic testing for HD is a valuable tool for diagnosis, prediction, and prenatal assessment.
  • Understanding repeat expansion mechanisms is crucial for managing HD risk.
  • Informed decision-making and emotional support are vital for individuals undergoing genetic testing.